Cite

HARVARD Citation

    Huo, C. et al. (2023). Immune-related adverse events are associated with therapeutic efficacy of immunotherapy in patients with melanoma brain metastases. Melanoma research. 33 (1), pp. 58-65. [Online]. 
  
Back to record